JAIME PRAT, M.D., Hospital de la Santa Creu I Sant Pau, Autonomous University, Barcelona, Spain and MARIA J. MERINO, M.D., National Cancer Institute, National Institutes of Health, Bethesda, MD
Over the past fifteen years, great advance in the knowledge about ovarian tumors and their histopathologic features has occurred. Accordingly, different new therapeutic modalities have been established.
Using a case study approach, common and uncommon tumors of the ovary will be discussed. Special emphasis will be placed on differential diagnosis based on study of hematoxylin-and-eosin stained slides and immunohistochemistry. In addition, well established prognostic factors and, only when appropriate, the usefulness of modern techniques will be discussed. By the end of the course, the participants will obtain: 1) an increased knowledge of histopathologic and immunohistochemical criteria for the differential diagnosis of various ovarian tumors; 2) an in-depth knowledge of ovarian borderline tumors with emphasis on their biologic behavior and clinically useful managerial classification; and 3) established and investigational prognostic indicators.
The course is designed for practitioners and pathology residents wishing to update their knowledge of ovarian tumors. Case histories and a limited number of loan sets of microscopic slides will be available for advance mailing. A detailed syllabus with annotated references will be distributed at the time of the course. All registrants will be mailed a set of transparencies for retention after the meeting. (Last Scheduled Presentation)